Filing Flows › Sanofi (SNY) › Q2 2026 › vs Q1 2026
Sanofi (SNY) Q2 2026 vs Q1 2026 (quarter over quarter)
Sanofi's revenue rose $1.1B (+10%) from $10.5B in Q1 2026 to $11.6B in Q2 2026.
Sanofi, Q2 2026: revenue $11.6B (+16% year over year), operating margin 9.0%, net earnings $377M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $11.6B | $10.5B | $1.1B | +10% |
| Income tax benefit | $451M | $420M | $31.0M | +7% |
| Costs & expenses | $12.0B | $10.9B | $1.1B | +10% |
| Operating costs | $10.6B | $8.4B | $2.2B | +26% |
| Interest & other, net | $1.1B | $921M | $200M | +22% |
| Net earnings | $377M | $1.6B | −$1.2B | -77% |
| Cost of revenue | $2.3B | $2.4B | −$89.0M | -4% |
| Research & development | $2.2B | $1.7B | $486M | +28% |
| Other operating costs | $6.0B | $4.2B | $1.8B | +42% |
Questions
How much did Sanofi's revenue grow quarter over quarter in Q2 2026?
Sanofi's revenue rose $1.1B (+10%) from $10.5B in Q1 2026 to $11.6B in Q2 2026.